BGB-23339-102

ithdrawn

Safety, Tolerability, and Pharmacokinetics of BGB-23339 in Healthy Japanese and Caucasian Subjects

Beigene Study ID info

BGB-23339-102

ClinicalTrials.gov ID info

Study Overview

Sex: All

Age: 18 Years / 55 Years

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years / 55 Years

No Study Documents